These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
982 related items for PubMed ID: 26517090
1. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. Zhao L, Ren Y, Tang H, Wang W, He Q, Sun J, Zhou X, Wang A. Oncotarget; 2015 Dec 29; 6(42):44538-50. PubMed ID: 26517090 [Abstract] [Full Text] [Related]
2. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. Qiao CY, Qiao TY, Jin H, Liu LL, Zheng MD, Wang ZL. Eur Rev Med Pharmacol Sci; 2020 Jan 29; 24(1):200-212. PubMed ID: 31957833 [Abstract] [Full Text] [Related]
3. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway. Wei T, Cong X, Wang XT, Xu XJ, Min SN, Ye P, Peng X, Wu LL, Yu GY. Oncotarget; 2017 Jan 24; 8(4):6663-6680. PubMed ID: 28035060 [Abstract] [Full Text] [Related]
4. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1. Fan S, Chen WX, Lv XB, Tang QL, Sun LJ, Liu BD, Zhong JL, Lin ZY, Wang YY, Li QX, Yu X, Zhang HQ, Li YL, Wen B, Zhang Z, Chen WL, Li JS. Cancer Lett; 2015 Jul 01; 362(2):183-91. PubMed ID: 25843291 [Abstract] [Full Text] [Related]
5. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells. Guo J, Jin D, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Miao S, Xi S. EBioMedicine; 2018 Sep 01; 35():204-221. PubMed ID: 30146342 [Abstract] [Full Text] [Related]
6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B. Cancer Med; 2017 Dec 01; 6(12):2897-2908. PubMed ID: 29125238 [Abstract] [Full Text] [Related]
7. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist. Peng F, Zhang H, Du Y, Tan P. Oncol Rep; 2015 Feb 01; 33(2):942-50. PubMed ID: 25501015 [Abstract] [Full Text] [Related]
8. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M, Chen W, Zhang H, Zhang Y, Ke F, Wu X, Zhang Y, Weng M, Liu Y, Gong W. Oncotarget; 2016 Dec 13; 7(50):83060-83070. PubMed ID: 27825112 [Abstract] [Full Text] [Related]
9. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. Liu M, Wang J, Huang H, Hou J, Zhang B, Wang A. Biochem Biophys Res Commun; 2013 Nov 15; 441(2):364-70. PubMed ID: 24148247 [Abstract] [Full Text] [Related]
10. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. Chen W, Wang P, Lu Y, Jin T, Lei X, Liu M, Zhuang P, Liao J, Lin Z, Li B, Peng Y, Pan G, Lv X, Zhang H, Ou Z, Xie S, Lin X, Sun S, Ferrone S, Tannous BA, Ruan Y, Li J, Fan S. Theranostics; 2019 Nov 15; 9(20):5739-5754. PubMed ID: 31534516 [Abstract] [Full Text] [Related]
11. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway. Duan M, Du X, Ren G, Zhang Y, Zheng Y, Sun S, Zhang J. Mol Med Rep; 2018 Aug 15; 18(2):1651-1659. PubMed ID: 29845251 [Abstract] [Full Text] [Related]
12. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. Qiu K, Huang Z, Huang Z, He Z, You S. Arch Oral Biol; 2016 Jun 15; 66():92-7. PubMed ID: 26943814 [Abstract] [Full Text] [Related]
13. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Xie SL, Fan S, Zhang SY, Chen WX, Li QX, Pan GK, Zhang HQ, Wang WW, Weng B, Zhang Z, Li JS, Lin ZY. Int J Cancer; 2018 Mar 15; 142(6):1252-1265. PubMed ID: 29071717 [Abstract] [Full Text] [Related]
14. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY, Jiao DM, Wang J, Hu H, Tang X, Chen J, Mou H, Lu W. Oncotarget; 2016 Apr 26; 7(17):24510-26. PubMed ID: 27014910 [Abstract] [Full Text] [Related]
15. Dysregulation of AKT1, a miR-138 target gene, is involved in the migration and invasion of tongue squamous cell carcinoma. Ji M, Wang W, Yan W, Chen D, Ding X, Wang A. J Oral Pathol Med; 2017 Oct 26; 46(9):731-737. PubMed ID: 28122142 [Abstract] [Full Text] [Related]
16. Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma. Xie N, Wang C, Zhuang Z, Hou J, Liu X, Wu Y, Liu H, Huang H. Oncotarget; 2016 Oct 04; 7(40):65744-65757. PubMed ID: 27582550 [Abstract] [Full Text] [Related]
17. Retinoic acid receptor-related orphan receptor alpha and synthetic RORα agonist against invasion and metastasis in tongue squamous cell carcinoma. Wang M, Zeng R, Zheng S, Qian Y. Biochem Biophys Res Commun; 2024 Nov 12; 733():150421. PubMed ID: 39047426 [Abstract] [Full Text] [Related]
18. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10. Wu K, Yang Y, Zhao J, Zhao S. Cancer Lett; 2016 Feb 01; 371(1):125-33. PubMed ID: 26655271 [Abstract] [Full Text] [Related]
19. Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2. Tang YL, Jiang J, Liu J, Zheng M, He YW, Chen W, Fan YL, Chen QM, Liao CH, Liang XH. J Oral Pathol Med; 2015 May 01; 44(5):337-44. PubMed ID: 25048179 [Abstract] [Full Text] [Related]